Article ID Journal Published Year Pages File Type
3331936 Hematology/Oncology Clinics of North America 2009 12 Pages PDF
Abstract

Acquired severe aplastic anemia can be treated successfully with either immunosuppressive therapy or bone marrow transplantation. Although immunosuppressive therapy can be readily administered to all patients, it is not a curative approach and is associated with a higher risk of clonal evolution than is transplantation, which yields rapid and long-lasting hematologic remission. This article reviews the key diagnostic and prognostic factors that influence the choice of therapy in patients with acquired aplastic anemia.

Related Topics
Health Sciences Medicine and Dentistry Hematology
Authors
, ,